{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:00:25Z","timestamp":1792839625202,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Spanish Ministry of Economy and Competitiveness","award":["PI12\/00380"],"award-info":[{"award-number":["PI12\/00380"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["PI15\/01132"],"award-info":[{"award-number":["PI15\/01132"]}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["PI18\/01075"],"award-info":[{"award-number":["PI18\/01075"]}]},{"name":"Miguel Servet Programme","award":["CON14\/00129"],"award-info":[{"award-number":["CON14\/00129"]}]},{"DOI":"10.13039\/100003760","name":"Fondo de Investigaci\u00f3n en Salud","doi-asserted-by":"publisher","award":["PI14\/00399"],"award-info":[{"award-number":["PI14\/00399"]}],"id":[{"id":"10.13039\/100003760","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003760","name":"Fondo de Investigaci\u00f3n en Salud","doi-asserted-by":"publisher","award":["PI17\/00022"],"award-info":[{"award-number":["PI17\/00022"]}],"id":[{"id":"10.13039\/100003760","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cRamon y Cajal\u201d Programme","award":["RYC-2015-17755"],"award-info":[{"award-number":["RYC-2015-17755"]}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ISCIII CIBERehd"},{"DOI":"10.13039\/501100019124","name":"\u201cDiputaci\u00f3n Foral de Gipuzkoa\u201d","doi-asserted-by":"crossref","award":["DFG15\/010"],"award-info":[{"award-number":["DFG15\/010"]}],"id":[{"id":"10.13039\/501100019124","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019124","name":"\u201cDiputaci\u00f3n Foral de Gipuzkoa\u201d","doi-asserted-by":"crossref","award":["DFG16\/004"],"award-info":[{"award-number":["DFG16\/004"]}],"id":[{"id":"10.13039\/501100019124","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000156","name":"BIOEF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basque Foundation for Innovation and Health Research","award":["BIO15\/CA\/016\/BD"],"award-info":[{"award-number":["BIO15\/CA\/016\/BD"]}]},{"name":"Department of Health of the Basque Country","award":["2015111100"],"award-info":[{"award-number":["2015111100"]}]},{"name":"Department of Health of the Basque Country","award":["2017111010"],"award-info":[{"award-number":["2017111010"]}]},{"DOI":"10.13039\/501100002704","name":"\u201cFundaci\u00f3n Cient\u00edfica de la Asociaci\u00f3n Espa\u00f1ola Contra el Cancer\u201d","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AECC Scientific Foundation"},{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["PRE_2015_1_0126"],"award-info":[{"award-number":["PRE_2015_1_0126"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jhep.2018.08.020","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T05:18:00Z","timestamp":1536124680000},"page":"1371-1383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?"],"prefix":"10.1016","volume":"69","author":[{"given":"Pedro M.","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Perugorria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Santos-Laso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bujanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus M.","family":"Banales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.08.020_b0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2018.08.020_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1053\/j.gastro.2015.08.031","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"149","author":"Beuers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.08.020_b0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-230X-10-100","article-title":"Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China","volume":"10","author":"Liu","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.020_b0030","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0035","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1111\/liv.12479","article-title":"Geoepidemiology and space-time analysis of Primary biliary cirrhosis in Crete, Greece","volume":"34","author":"Koulentaki","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2018.08.020_b0040","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","article-title":"Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England","volume":"26","author":"Metcalf","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2018.08.020_b0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.1840120116","article-title":"The demography of primary biliary cirrhosis in Ontario, Canada","volume":"12","author":"Witt-Sullivan","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0050","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","article-title":"Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group","volume":"36","author":"Watson","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.08.020_b0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.08.020_b0060","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Zoller","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.08.020_b0070","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.23210","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study","volume":"50","author":"Myers","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0075","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2018.08.020_b0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.172.3.961","article-title":"Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis","volume":"172","author":"Courvalin","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI114696","article-title":"The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore","volume":"86","author":"Courvalin","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2018.08.020_b0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","article-title":"Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis","volume":"42","author":"Sternsdorf","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0095","article-title":"Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.08.020_b0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-3083.1992.tb03224.x","article-title":"Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution","volume":"36","author":"Szostecki","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1568-9972(02)00050-2","article-title":"Primary biliary cirrhosis and hepatocellular carcinoma","volume":"1","author":"Findor","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2018.08.020_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gutjnl-2014-308351","article-title":"Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study","volume":"65","author":"Trivedi","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.08.020_b0120","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0135","first-page":"759","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000324144","article-title":"Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis","volume":"29","author":"Medina","year":"2011","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2018.08.020_b0145","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0150","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0155","doi-asserted-by":"crossref","first-page":"e758","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrgastro.2015.12","article-title":"Novel therapeutic targets in primary biliary cirrhosis","volume":"12","author":"Dyson","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0170","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0175","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2018.08.020_b0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-008-8087-9","article-title":"Bacteria and primary biliary cirrhosis","volume":"36","author":"Bogdanos","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0190","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0195","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.bor.0000130538.76808.c2","article-title":"Bacteria and human autoimmunity: the case of primary biliary cirrhosis","volume":"16","author":"Selmi","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0200","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2010.12.009","article-title":"The evidence supports a viral aetiology for primary biliary cirrhosis","volume":"54","author":"Mason","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0205","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1038\/ncomms6236","article-title":"Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes","volume":"5","author":"Kim","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.08.020_b0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.humimm.2012.10.022","article-title":"Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis","volume":"74","author":"Morita","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0215","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clinre.2012.07.001","article-title":"Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C","volume":"36","author":"Benias","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.020_b0220","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.24194","article-title":"Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis","volume":"53","author":"Shimoda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/00365521.2010.539624","article-title":"Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis","volume":"46","author":"Zhao","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.020_b0230","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.20859","article-title":"Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis","volume":"42","author":"Mao","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0235","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/labinvest.3700285","article-title":"Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis","volume":"85","author":"Takii","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2018.08.020_b0240","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2004.11.005","article-title":"Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis","volume":"128","author":"Kikuchi","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.it.2009.05.006","article-title":"The role of environmental factors in primary biliary cirrhosis","volume":"30","author":"Selmi","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0250","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1155\/2010\/752314","article-title":"Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis","volume":"29","author":"Selmi","year":"2010","journal-title":"Dis Markers"},{"key":"10.1016\/j.jhep.2018.08.020_b0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0260","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","article-title":"Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.08.020_b0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2011.03.031","article-title":"Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis","volume":"56","author":"Corpechot","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0275","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.21423","article-title":"Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment","volume":"44","author":"Zein","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0280","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0895-4356(00)00370-X","article-title":"Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan","volume":"54","author":"Ohba","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2018.08.020_b0285","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0290","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/jhered\/esv059","article-title":"XWAS: a software toolset for genetic data analysis and association studies of the X chromosome","volume":"106","author":"Gao","year":"2015","journal-title":"J Hered"},{"key":"10.1016\/j.jhep.2018.08.020_b0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0300","first-page":"128","article-title":"Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis","volume":"5","author":"Selmi","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0305","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.jhep.2018.08.020_b0310","first-page":"112","article-title":"DNA polymorphism of HLA class II genes in primary biliary cirrhosis","volume":"35","author":"Morling","year":"1992","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jhep.2018.08.020_b0315","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0320","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ng.631","article-title":"Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis","volume":"42","author":"Hirschfield","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0325","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ng.627","article-title":"Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis","volume":"42","author":"Liu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.789","article-title":"Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis","volume":"43","author":"Mells","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0335","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ajhg.2012.08.010","article-title":"Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population","volume":"91","author":"Nakamura","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0340","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1038\/ncomms14828","article-title":"A genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2018.08.020_b0345","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0355","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0360","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0365","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.24355","article-title":"Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis","volume":"54","author":"Rong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0370","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0375","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhep.2018.08.020_b0380","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.3748\/wjg.v12.i22.3496","article-title":"Cholangiocyte anion exchange and biliary bicarbonate excretion","volume":"12","author":"Banales","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.020_b0385","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"Arenas","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2018.08.020_b0390","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/hep.1840190613","article-title":"Immunohistochemical detection of chloride\/bicarbonate anion exchangers in human liver","volume":"19","author":"Martinez-Anso","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0395","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.21042","article-title":"Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger","volume":"43","author":"Banales","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0400","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/hep.23403","article-title":"Bicarbonate secretion of mouse cholangiocytes involves Na(+)-HCO(3)(\u2212) cotransport in addition to Na(+)-independent Cl(\u2212)\/HCO(3)(\u2212) exchange","volume":"51","author":"Uriarte","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0405","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0410","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3\u2212 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0415","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1126\/science.289.5479.625","article-title":"Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor","volume":"289","author":"Chen","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jhep.2018.08.020_b0420","doi-asserted-by":"crossref","first-page":"12146","DOI":"10.1074\/jbc.M710590200","article-title":"Activation of cyclic AMP Signaling in Ae2-deficient mouse fibroblasts","volume":"283","author":"Mardones","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2018.08.020_b0425","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0430","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0016-5085(93)90735-U","article-title":"Abnormal expression of anion exchanger genes in primary biliary cirrhosis","volume":"105","author":"Prieto","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0435","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0440","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","article-title":"Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis","volume":"25","author":"Medina","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0445","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","article-title":"Defective regulation of cholangiocyte Cl\u2212\/HCO3(\u2212) and Na+\/H+ exchanger activities in primary biliary cirrhosis","volume":"35","author":"Melero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0450","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0455","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0460","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/eji.201344218","article-title":"Anion exchanger 2 is critical for CD8(+) T cells to maintain pHi homeostasis and modulate immune responses","volume":"44","author":"Concepcion","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0465","doi-asserted-by":"crossref","first-page":"28588","DOI":"10.18632\/oncotarget.5665","article-title":"CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a, b\u2212\/\u2212 mice favoring autoimmune cholangitis","volume":"6","author":"Concepcion","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2018.08.020_b0470","doi-asserted-by":"crossref","DOI":"10.1038\/s41374-018-0045-4","article-title":"An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis","author":"Sasaki","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2018.08.020_b0475","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0480","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/hmg\/ddq513","article-title":"Replication timing-related and gene body-specific methylation of active human genes","volume":"20","author":"Aran","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/epi.6.1.13405","article-title":"Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis","volume":"6","author":"Mitchell","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.jhep.2018.08.020_b0490","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0495","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","article-title":"DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis","volume":"7","author":"Lleo","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jhep.2018.08.020_b0500","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0505","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jcb.20106","article-title":"Application of mass spectrometry to the identification and quantification of histone post-translational modifications","volume":"92","author":"Freitas","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jhep.2018.08.020_b0510","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2018.08.020_b0515","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10875-010-9492-4","article-title":"Beta-Arrestin 1 modulates functions of autoimmune T cells from primary biliary cirrhosis patients","volume":"31","author":"Hu","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0520","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinre.2015.10.001","article-title":"MicroRNAs in cholangiopathies: potential diagnostic and therapeutic tools","volume":"40","author":"Esparza-Baquer","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.020_b0530","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.bbadis.2017.06.026","article-title":"MicroRNAs and extracellular vesicles in cholangiopathies","volume":"1864","author":"Olaizola","year":"2018","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2018.08.020_b0535","doi-asserted-by":"crossref","first-page":"J207","DOI":"10.1016\/j.jaut.2009.12.006","article-title":"Epigenetics and autoimmunity","volume":"34","author":"Brooks","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2018.08.020_b0540","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","article-title":"Primary biliary cirrhosis is associated with altered hepatic microRNA expression","volume":"32","author":"Padgett","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2018.08.020_b0545","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl\u2212\/HCO3\u2212 anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0550","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2018.08.020_b0555","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0560","first-page":"1031","article-title":"Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1\/B7 expression","volume":"21","author":"Tsuneyama","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.020_b0565","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1136\/gut.34.9.1245","article-title":"Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines","volume":"34","author":"Ayres","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2018.08.020_b0570","first-page":"317","article-title":"Immunoelectron microscopic localization of MHC class 1 and 2 antigens on bile duct epithelial cells in patients with primary biliary cirrhosis","volume":"48","author":"Nishimoto","year":"1994","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jhep.2018.08.020_b0575","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2169\/internalmedicine.42.947","article-title":"Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 protein and messenger RNA in primary biliary cirrhosis","volume":"42","author":"Yokomori","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0580","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2007.08.020","article-title":"Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile","volume":"133","author":"Minagawa","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0585","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/gast.2001.26280","article-title":"Bile duct epithelia regulate biliary bicarbonate excretion in normal rat liver","volume":"121","author":"Hirata","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0590","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0016-5085(03)01201-0","article-title":"Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis","volume":"125","author":"Shibao","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0595","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2353\/ajpath.2006.051237","article-title":"Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis","volume":"169","author":"Sasaki","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2018.08.020_b0600","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2018.08.020_b0605","article-title":"MiRNA-21 ablation protects against liver injury and necroptosis in cholestasis","author":"Afonso","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2018.08.020_b0610","doi-asserted-by":"crossref","first-page":"e2390","DOI":"10.1038\/cddis.2016.280","article-title":"Activation of necroptosis in human and experimental cholestasis","volume":"7","author":"Afonso","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jhep.2018.08.020_b0615","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2012.12.013","article-title":"Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse","volume":"41","author":"Ando","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2018.08.020_b0620","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020289","article-title":"Decreased expression of vitamin D receptor affects an immune response in primary biliary cholangitis via the VDR-miRNA155-SOCS1 pathway","volume":"18","author":"Kempinska-Podhorodecka","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhep.2018.08.020_b0625","doi-asserted-by":"crossref","first-page":"44769","DOI":"10.1038\/srep44769","article-title":"Protection against oxidative stress mediated by the Nrf2\/Keap1 axis is impaired in Primary Biliary Cholangitis","volume":"7","author":"Wasik","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2018.08.020_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111424","article-title":"Serum microRNAs as potential biomarkers of primary biliary cirrhosis","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.08.020_b0635","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/labinvest.2016.95","article-title":"MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis","volume":"96","author":"Katsumi","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2018.08.020_b0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066086","article-title":"Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers","volume":"8","author":"Ninomiya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.08.020_b0645","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3892\/mmr.2016.5606","article-title":"Identification of microRNA profiles associated with refractory primary biliary cirrhosis","volume":"14","author":"Sakamoto","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jhep.2018.08.020_b0650","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jhep.2017.02.002","article-title":"MiR-425 regulates inflammatory cytokine production in CD4(+) T cells via N-Ras upregulation in primary biliary cholangitis","volume":"66","author":"Nakagawa","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0655","first-page":"533","article-title":"Qin Q","volume":"21","author":"Qian","year":"2013","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.jhep.2018.08.020_b0660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/ijmm.2016.2610","article-title":"Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis","volume":"38","author":"Liang","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0665","article-title":"MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2018.08.020_b0670","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1111\/hepr.12198","article-title":"Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients","volume":"44","author":"Katsushima","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2018.08.020_b0675","first-page":"2265","article-title":"MicroRNA profiling in T cells of peripheral blood mononuclear cell from patients with primary biliary cirrhosis","volume":"92","author":"Qian","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jhep.2018.08.020_b0680","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jgh.12040","article-title":"Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis","volume":"28","author":"Qin","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.08.020_b0685","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/cmi.2015.86","article-title":"The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis","volume":"14","author":"Tomiyama","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0690","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","article-title":"Evolution and functions of long noncoding RNAs","volume":"136","author":"Ponting","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2018.08.020_b0695","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4161\/rna.7.5.13216","article-title":"Long noncoding RNA in genome regulation: prospects and mechanisms","volume":"7","author":"Hung","year":"2010","journal-title":"RNA Biol"},{"key":"10.1016\/j.jhep.2018.08.020_b0700","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0705","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev-genom-091212-153450","article-title":"Mapping of immune-mediated disease genes","volume":"14","author":"Ricano-Ponce","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.jhep.2018.08.020_b0710","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13073-014-0088-0","article-title":"Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell-type specificity","volume":"6","author":"Hrdlickova","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0715","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.4049\/jimmunol.0900603","article-title":"Genome-wide identification of long noncoding RNAs in CD8+ T cells","volume":"182","author":"Pang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2018.08.020_b0720","first-page":"2656","article-title":"Increased expression of lncRNA AK053349 in peripheral blood mononuclear cells from patients with primary biliary cirrhosis and its clinical significance","volume":"34","author":"Zhang","year":"2013","journal-title":"Int J Lab Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0725","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMc1307787","article-title":"HCV infection and miravirsen","volume":"369","author":"Sanchez-Nino","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2018.08.020_b0730","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(16)31715-9","article-title":"Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial","volume":"389","author":"van der Ree","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2018.08.020_b0735","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00001574-200405000-00012","article-title":"Cholangiocyte biology","volume":"20","author":"Tietz","year":"2004","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.020_b0740","doi-asserted-by":"crossref","first-page":"20413","DOI":"10.1074\/jbc.M302108200","article-title":"Agonist-induced coordinated trafficking of functionally related transport proteins for water and ions in cholangiocytes","volume":"278","author":"Tietz","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2018.08.020_b0745","first-page":"G303","article-title":"Role of kinases and phosphatases in the regulation of fluid secretion and Cl\u2212\/HCO3\u2212 exchange in cholangiocytes","volume":"273","author":"Alvaro","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2018.08.020_b0750","doi-asserted-by":"crossref","first-page":"C1344","DOI":"10.1152\/ajpcell.2001.281.4.C1344","article-title":"Regulation of AE2 anion exchanger by intracellular pH: critical regions of the NH(2)-terminal cytoplasmic domain","volume":"281","author":"Stewart","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jhep.2018.08.020_b0755","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0016-5085(93)91085-V","article-title":"Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells","volume":"105","author":"Cohn","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.020_b0760","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1172\/JCI116188","article-title":"Regulation of membrane chloride currents in rat bile duct epithelial cells","volume":"91","author":"Fitz","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2018.08.020_b0765","doi-asserted-by":"crossref","first-page":"G87","DOI":"10.1152\/ajpgi.00154.2012","article-title":"Mechanosensitive Cl\u2212 secretion in biliary epithelium mediated through TMEM16A","volume":"304","author":"Dutta","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2018.08.020_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2018.05.010","article-title":"Regulation of bile secretion by calcium signaling in health and disease","author":"Trampert","year":"2018","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818323626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818323626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:34:44Z","timestamp":1759174484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818323626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":154,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0168827818323626"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.08.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary biliary cholangitis: A tale of epigenetically-induced secretory failure?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}